J. Palaty et Fs. Abbott, STRUCTURE-ACTIVITY-RELATIONSHIPS OF UNSATURATED ANALOGS OF VALPROIC ACID, Journal of medicinal chemistry, 38(17), 1995, pp. 3398-3406
The principal metabolite of valproic acid (VPA), 2-ene VPA, appears to
share most of VPA's pharmacological and therapeutic properties while
lacking its hepatotoxicity and teratogenicity, thus making it a useful
lead compound for the development of safer antiepileptic drugs. Analo
gues of 2-ene VPA were evaluated for anticonvulsant activity in mice u
sing the subcutaneous pentylenetetrazole test. Cyclooctylideneacetic a
cid exhibited a potency markedly exceeding that of VPA itself with onl
y modest levels of sedation. Potency, as either ED(50) or brain concen
tration, was highly correlated (r > 0.85) with volume and lipophilicit
y rather than with one of the shape parameters calculated by molecular
modeling techniques, arguing against the existence of a specific rece
ptor site. Instead, a role for the plasma membrane in mediating the an
ticonvulsant effect is suggested.